Black Other Liab vs Other Current Liab Analysis

BDTX Stock

USD 5.14 0.10 1.91%

Black Diamond financial indicator trend analysis is way more than just evaluating Black Diamond Therap prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Black Diamond Therap is a good investment. Please check the relationship between Black Diamond Other Liab and its Other Current Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Black Diamond Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

Other Liab vs Other Current Liab

Other Liab vs Other Current Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Black Diamond Therap Other Liab account and Other Current Liab. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Black Diamond's Other Liab and Other Current Liab is -0.17. Overlapping area represents the amount of variation of Other Liab that can explain the historical movement of Other Current Liab in the same time period over historical financial statements of Black Diamond Therapeutics, assuming nothing else is changed. The correlation between historical values of Black Diamond's Other Liab and Other Current Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Liab of Black Diamond Therapeutics are associated (or correlated) with its Other Current Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Current Liab has no effect on the direction of Other Liab i.e., Black Diamond's Other Liab and Other Current Liab go up and down completely randomly.

Correlation Coefficient

-0.17

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Other Liab

Other Current Liab

Most indicators from Black Diamond's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Black Diamond Therap current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Black Diamond Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

Selling General Administrative is likely to drop to about 18.4 M in 2024. Issuance Of Capital Stock is likely to drop to about 62.3 M in 2024

	2021	2022	2023	2024 (projected)
Reconciled Depreciation	205K	508K	437K	458.9K
Total Operating Expenses	126.9M	92.8M	86.0M	65.6M

Reconciled Depreciation Total Operating Expenses

Black Diamond fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Surpluse	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets	Net Working Capital
Total Assets		0.82	0.84	-0.4	-0.09	0.88	0.69	-0.22	-0.65	0.92	0.57	0.72	0.56	0.41	1.0	0.83	0.87	0.22	0.82	0.89	0.01	0.5	0.89	0.67	1.0	0.99
Other Current Liab	0.82		0.99	-0.39	-0.17	0.84	0.95	-0.44	-0.83	0.93	0.35	0.96	0.65	0.27	0.77	0.94	0.83	-0.07	0.91	0.93	0.35	0.62	0.83	0.89	0.77	0.74
Total Current Liabilities	0.84	0.99		-0.39	-0.17	0.84	0.95	-0.4	-0.86	0.94	0.39	0.96	0.63	0.3	0.79	0.96	0.88	-0.02	0.93	0.94	0.36	0.57	0.82	0.87	0.79	0.76
Total Stockholder Equity	-0.4	-0.39	-0.39		0.05	-0.38	-0.49	-0.05	0.11	-0.42	-0.09	-0.51	-0.49	-0.53	-0.36	-0.38	-0.29	-0.02	-0.23	-0.61	0.52	-0.47	-0.4	0.01	-0.36	-0.36
Other Liab	-0.09	-0.17	-0.17	0.05		-0.18	-0.17	-0.49	0.16	-0.15	0.12	-0.17	-0.13	-0.12	-0.08	-0.18	-0.1	0.18	-0.18	-0.19	-0.1	0.0	-0.17	-0.15	-0.08	-0.07
Net Tangible Assets	0.88	0.84	0.84	-0.38	-0.18		0.71	-0.47	-0.62	0.79	0.13	0.71	0.32	0.02	0.87	0.89	0.68	-0.25	0.84	0.88	0.05	0.31	1.0	0.66	0.87	0.86
Property Plant And Equipment Net	0.69	0.95	0.95	-0.49	-0.17	0.71		-0.38	-0.88	0.84	0.29	0.99	0.6	0.32	0.62	0.92	0.81	-0.09	0.89	0.9	0.41	0.53	0.7	0.79	0.62	0.59
Net Debt	-0.22	-0.44	-0.4	-0.05	-0.49	-0.47	-0.38		0.34	-0.22	0.3	-0.35	0.08	0.56	-0.19	-0.41	-0.1	0.56	-0.43	-0.31	-0.35	-0.07	-0.46	-0.5	-0.19	-0.17
Retained Earnings	-0.65	-0.83	-0.86	0.11	0.16	-0.62	-0.88	0.34		-0.74	-0.37	-0.85	-0.37	-0.18	-0.59	-0.86	-0.84	0.0	-0.94	-0.76	-0.7	-0.25	-0.6	-0.81	-0.59	-0.56
Accounts Payable	0.92	0.93	0.94	-0.42	-0.15	0.79	0.84	-0.22	-0.74		0.62	0.88	0.79	0.52	0.89	0.85	0.91	0.25	0.83	0.92	0.17	0.73	0.78	0.82	0.89	0.88
Cash	0.57	0.35	0.39	-0.09	0.12	0.13	0.29	0.3	-0.37	0.62		0.36	0.67	0.81	0.57	0.26	0.72	0.91	0.31	0.37	0.04	0.56	0.12	0.35	0.57	0.58
Non Current Assets Total	0.72	0.96	0.96	-0.51	-0.17	0.71	0.99	-0.35	-0.85	0.88	0.36		0.69	0.39	0.65	0.9	0.82	-0.02	0.87	0.92	0.37	0.62	0.7	0.81	0.66	0.63
Non Currrent Assets Other	0.56	0.65	0.63	-0.49	-0.13	0.32	0.6	0.08	-0.37	0.79	0.67	0.69		0.77	0.53	0.42	0.6	0.46	0.38	0.62	-0.03	0.97	0.32	0.58	0.52	0.51
Other Assets	0.41	0.27	0.3	-0.53	-0.12	0.02	0.32	0.56	-0.18	0.52	0.81	0.39	0.77		0.4	0.18	0.55	0.8	0.13	0.39	-0.27	0.65	0.03	0.1	0.4	0.4
Cash And Short Term Investments	1.0	0.77	0.79	-0.36	-0.08	0.87	0.62	-0.19	-0.59	0.89	0.57	0.65	0.53	0.4		0.79	0.85	0.25	0.77	0.85	-0.04	0.47	0.87	0.62	1.0	1.0
Common Stock Total Equity	0.83	0.94	0.96	-0.38	-0.18	0.89	0.92	-0.41	-0.86	0.85	0.26	0.9	0.42	0.18	0.79		0.86	-0.13	0.95	0.92	0.32	0.35	0.88	0.76	0.79	0.77
Common Stock Shares Outstanding	0.87	0.83	0.88	-0.29	-0.1	0.68	0.81	-0.1	-0.84	0.91	0.72	0.82	0.6	0.55	0.85	0.86		0.39	0.85	0.83	0.3	0.48	0.67	0.71	0.85	0.83
Non Current Liabilities Total	0.22	-0.07	-0.02	-0.02	0.18	-0.25	-0.09	0.56	0.0	0.25	0.91	-0.02	0.46	0.8	0.25	-0.13	0.39		-0.1	0.0	-0.17	0.37	-0.25	-0.05	0.25	0.27
Capital Surpluse	0.82	0.91	0.93	-0.23	-0.18	0.84	0.89	-0.43	-0.94	0.83	0.31	0.87	0.38	0.13	0.77	0.95	0.85	-0.1		0.89	0.5	0.3	0.83	0.84	0.78	0.75
Other Current Assets	0.89	0.93	0.94	-0.61	-0.19	0.88	0.9	-0.31	-0.76	0.92	0.37	0.92	0.62	0.39	0.85	0.92	0.83	0.0	0.89		0.12	0.56	0.88	0.72	0.86	0.84
Other Stockholder Equity	0.01	0.35	0.36	0.52	-0.1	0.05	0.41	-0.35	-0.7	0.17	0.04	0.37	-0.03	-0.27	-0.04	0.32	0.3	-0.17	0.5	0.12		-0.09	0.03	0.62	-0.04	-0.07
Total Liab	0.5	0.62	0.57	-0.47	0.0	0.31	0.53	-0.07	-0.25	0.73	0.56	0.62	0.97	0.65	0.47	0.35	0.48	0.37	0.3	0.56	-0.09		0.31	0.57	0.46	0.46
Net Invested Capital	0.89	0.83	0.82	-0.4	-0.17	1.0	0.7	-0.46	-0.6	0.78	0.12	0.7	0.32	0.03	0.87	0.88	0.67	-0.25	0.83	0.88	0.03	0.31		0.65	0.87	0.86
Property Plant And Equipment Gross	0.67	0.89	0.87	0.01	-0.15	0.66	0.79	-0.5	-0.81	0.82	0.35	0.81	0.58	0.1	0.62	0.76	0.71	-0.05	0.84	0.72	0.62	0.57	0.65		0.62	0.6
Total Current Assets	1.0	0.77	0.79	-0.36	-0.08	0.87	0.62	-0.19	-0.59	0.89	0.57	0.66	0.52	0.4	1.0	0.79	0.85	0.25	0.78	0.86	-0.04	0.46	0.87	0.62		1.0
Net Working Capital	0.99	0.74	0.76	-0.36	-0.07	0.86	0.59	-0.17	-0.56	0.88	0.58	0.63	0.51	0.4	1.0	0.77	0.83	0.27	0.75	0.84	-0.07	0.46	0.86	0.6	1.0

Click cells to compare fundamentals

Black Diamond Account Relationship Matchups

Black Diamond fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	158.3M	329.7M	247.7M	156.3M	158.6M	174.5M
Other Current Liab	2.9M	10.6M	19.2M	10.5M	14.2M	9.7M
Total Current Liabilities	4.9M	14.2M	23.6M	15.3M	19.6M	13.0M
Total Stockholder Equity	(51.0M)	(118.2M)	(243.8M)	(335.0M)	116.7M	122.6M
Net Tangible Assets	(47.2M)	307.8M	195.9M	115.7M	133.0M	100.8M
Property Plant And Equipment Net	164K	8.8M	30.7M	27.4M	23.7M	14.3M
Net Debt	45.9M	(25.9M)	(37.3M)	(6.2M)	(30.9M)	(29.4M)
Retained Earnings	(51.0M)	(118.2M)	(243.8M)	(335.0M)	(417.4M)	(396.6M)
Accounts Payable	2.0M	2.5M	4.1M	1.9M	2.3M	2.1M
Cash	154.7M	34.6M	65.8M	34.3M	56.2M	63.7M
Non Current Assets Total	3.6M	10.1M	37.9M	28.5M	24.5M	16.5M
Non Currrent Assets Other	3.4M	106K	5.9M	1.2M	823K	781.9K
Other Assets	2.4M	0.0	1.2M	1.2M	1.0	0.95
Cash And Short Term Investments	154.7M	315.1M	209.8M	122.8M	131.4M	156.1M
Common Stock Shares Outstanding	35.9M	32.9M	36.2M	36.3M	44.0M	32.4M
Liabilities And Stockholders Equity	158.3M	(96.3M)	247.7M	(294.4M)	158.6M	166.5M
Non Current Liabilities Total	200.6M	7.7M	28.1M	25.3M	22.2M	41.3M
Capital Surpluse	3.8M	425.4M	440.1M	452.5M	520.4M	546.4M
Other Current Assets	1.0M	4.5M	5.9M	4.9M	2.6M	3.0M
Other Stockholder Equity	(200.6M)	(330.3M)	409K	1.8M	534.2M	560.9M
Total Liab	209.3M	21.9M	491.5M	40.6M	41.8M	39.7M
Net Invested Capital	(47.2M)	307.8M	195.9M	115.7M	116.7M	104.8M
Property Plant And Equipment Gross	164K	8.8M	31.1M	2.6M	24.5M	25.7M
Total Current Assets	154.7M	319.6M	209.8M	127.7M	134.0M	158.0M
Accumulated Other Comprehensive Income	(1K)	614K	(414K)	(1.8M)	(27K)	(28.4K)
Net Working Capital	150.9M	305.3M	192.1M	112.4M	114.4M	146.1M
Property Plant Equipment	164K	8.8M	30.7M	2.6M	3.0M	2.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
CRM	Salesforce
MSFT	Microsoft

When determining whether Black Diamond Therap offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Black Diamond's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Black Diamond Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Black Diamond Therapeutics Stock:

How To Invest In Black

Details

Is Black Stock a good investment?

Details

What is Black Diamond's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Black Diamond Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Complementary Tools for Black Stock analysis

When running Black Diamond's price analysis, check to measure Black Diamond's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Black Diamond is operating at the current time. Most of Black Diamond's value examination focuses on studying past and present price action to predict the probability of Black Diamond's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Black Diamond's price. Additionally, you may evaluate how the addition of Black Diamond to your portfolios can decrease your overall portfolio volatility.

	Global Correlations Find global opportunities by holding instruments from different markets
	Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges
	Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets
	Risk-Return Analysis View associations between returns expected from investment and the risk you assume
	Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules

Is Black Diamond's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Black Diamond. If investors know Black will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Black Diamond listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.66)

Return On Assets

(0.38)

Return On Equity

(0.79)

The market value of Black Diamond Therap is measured differently than its book value, which is the value of Black that is recorded on the company's balance sheet. Investors also form their own opinion of Black Diamond's value that differs from its market value or its book value, called intrinsic value, which is Black Diamond's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Black Diamond's market value can be influenced by many factors that don't directly affect Black Diamond's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Black Diamond's value and its price as these two are different measures arrived at by different means. Investors typically determine if Black Diamond is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Black Diamond's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Black Other Liab vs Other Current Liab Analysis

Other Liab vs Other Current Liab

Other Liab vs Other Current Liab Correlation Analysis

Correlation Coefficient

Other Liab

Other Current Liab

Black Diamond fundamental ratios Correlations

Black Diamond Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Black Diamond fundamental ratios Accounts

Also Currently Popular

Complementary Tools for Black Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Net Tangible Assets
Total Current Assets	+ 1.0	Cash And Short Term Investments
Net Working Capital	+ 1.0	Cash And Short Term Investments
Net Working Capital	+ 1.0	Total Current Assets

Capital Surpluse	- 0.94	Retained Earnings
Retained Earnings	- 0.88	Property Plant And Equipment Net
Common Stock Total Equity	- 0.86	Retained Earnings
Retained Earnings	- 0.86	Total Current Liabilities
Non Current Assets Total	- 0.85	Retained Earnings
Common Stock Shares Outstanding	- 0.84	Retained Earnings